The colonic epithelial layer is a complex and dynamic structure that consists of multiple cell types, including goblet cells, enterocytes, Paneth cells, enteroendocrine cells, and intestinal stem cells (1). Each of these cells plays a crucial role in regulating various aspects of colonic physiology, such as mucosal formation, colonic absorption, colonic motility, immunity, and regeneration (2). Although these cells are derived from colonic stem cells (3), the mechanisms underlying their diversification during development are not yet fully understood.
Organoids, which are three-dimensional structures that recapitulate the process of organ formation
The aim of this study was to evaluate the biological significance of peripheral neuron contributions in the formation of colonic organoids. We co-cultured colonic organoids with human embryonic stem cell (hESC)-derived peripheral neurons following induction of colonic specification through temporarily restricted stimulation of bone morphogenetic protein (BMP). Our investigation revealed that substance P (SP) spontaneously released from immature peripheral neurons plays a critical role in the development of colonic epithelial cells, specifically colon enterochromaffin cells. Our findings highlight the essential role of inter-organ interactions in organoid development and provide insights into the mechanisms underlying colonic epithelial cell differentiation.
The hESC line WA09 (H9) was obtained from WiCell. The cells were maintained in Essential 8 medium (Thermo Fisher, USA) on iMatrix-511 coating material (Matrixome, Japan) under a 5% CO2 condition in a humidified incu-bator. To prevent any unintended effects of genetic mutations, hESCs between passages 30 to 40 were collected using either Versene solution (Thermo Fisher, USA) or Accutase (Sigma Aldrich, USA) for further experiments. All experiments involving hESCs were conducted under institutional IRB regulation KHSIRB-20-489 approved by Kyung Hee University (13).
To generate colonic organoids, we modified previously reported protocols (14-16). Briefly, 2.4 million hESCs were plated in a 24-well plate and allowed to reach 70% confluency as day 0. From day 0 to day 3, definitive endoderm (DE) was induced using RPMI 1640 medium (Welgene, Korea) containing 2% fetal bovine serum (FBS) (Welgene, Korea), 3 uM CHIR99021 (Sigma Aldrich, USA), and 100 ng/ml Activin A (Peprotech, USA). From day 4 to day 7, hindgut cells were differentiated using DMEM/F-12 medium (Welgene, Korea) containing 2% FBS, 1% B27 (Thermo Fisher, USA), 3 uM CHIR99021, and 500 ng/ml fibroblast growth factor 4 (FGF4) (Peprotech, USA), and then the resulting cell aggregates were embedded in Geltrex (Thermo Fisher, USA) after detachment using dispase (Thermo Fisher, USA). From day 8, DMEM/F-12 medium containing 1% B-27, 3 uM CHIR99021, 100 nM LDN193189 (STEMGENT, USA), and 100 ng/ml epidermal growth factor (EGF) (Peprotech, USA) was applied continuously, and from day 14 to day 20, 20 ng/ml BMP4 (Peprotech, USA) was temporarily added to the same medium composition to generate colonic organoids.
To differentiate NCSCs from PHOX2B::eGFP reporter hESCs, colonies were dissociated into single cells using Accutase (Sigma Aldrich) and plated on Geltrex (Thermo Fisher, USA), allowing them to reach 70%∼80% confluence following previous protocols (17). Differentiation into NCSCs was achieved by gradually changing Essential 8 medium to Neurobasal medium (Thermo Fisher, USA) supplemented with B27 and N-2 (Thermo Fisher, USA), containing 500 nM LDN193189 and 10 μM SB431542 for the first three days, followed by the addition of 3 μM CHIR99021 for an additional eight days. FACS sorting was used to isolate NCSCs expressing surface antigen p75 nerve growth factor receptor (NGFR) and human natural killer 1 (HNK-1). Enteric NCSCs were differentiated using a previously reported protocol as a control (18). After reaching 70%∼80% confluence on Geltrex, cells were treated with 500 nM LDN193189 and 10 μM SB431542 in gradually changing Neurobasal medium from day 0 to day 3. From day 4 to day 6, cells were treated with 3 μM CHIR99021, SB431542, 10 μM DAPT (Cayman Chemi-cal, USA), and 0.2 μM PD173074 (Sigma Aldrich, USA). From day 7 to day 12, cells were treated with 100 ng/ml sonic hedgehog (SHH) (Peprotech, USA) and 1 μM purmorphamine (PMP) (Sigma Aldrich). From day 10 to 14, cells were treated with 10 μg/ml BMP4. On day 14, PHOX2B::eGFP-expressing cells were sorted by FACS. Peripheral neurons were further differentiated by adding 10 nM nerve growth factor (NGF) (Peprotech, USA), 20 nM brain derived neurotrophic factor (BDNF) (Peprotech, USA), 20 nM glial cell derived neurotrophic factor (GDNF) (Peprotech, USA), 100 μM dibutyryl cyclic adenosine monophosphate (dbcAMP) (Sigma Aldrich, USA), and 100 μM sodium L-ascorbate (Sigma Aldrich, USA) to the culture medium, and cells were cultured for an additional seven weeks (13).
FACS-sorted NGFR and HNK1 double-positive NCSCs (250,000 cells/well) were cultured on Matrigel-coated plates in Neurobasal medium supplemented with B27 and N-2, 20 ng/ml bFGF, and 20 ng/ml EGF for 24 hours. After washing the colonic organoids embedded in Matrigel with cold PBS, they were separated from the matrix using Cell Recovery Solution (Corning, USA). Approximately 50 organoids per well were allowed to naturally settle onto the NCSCs. The co-culture medium for colonic organoids and NCSCs was a 1:1 mixture of Neurobasal medium containing B27 and N-2 supplements and DMEM/F-12 medium. Half of the medium was changed every other day with fresh medium. To establish co-culture without direct contact between colonic organoids and NCSCs, NGFR and HNK1 double-positive NCSCs and colonic organoids were cultured separately on Matrigel-coated plates for 24 hours in B27 and N-2-supplemented Neurobasal medium containing 20 ng/ml EGF and 20 ng/ml bFGF or DMEM/F-12 medium. A transwell system was used, where the colonic organoids were cultured in the lower chamber and the NCSCs in the upper chamber, with the two chambers separated by a 0.4 μm pore membrane. The culture medium was a 1:1 mixture of Neurobasal medium and DMEM/F-12, and half of the medium was changed every other day with a fresh one.
For flow cytometry analysis, the cells were mechanically dissociated after exposure to Accutase and treated with 40 μg/ml DNase I (Roche Applied Science, Germa-ny) for 20 minutes at 37℃. Next, the cells were incubated with appropriate antibodies for 1 hour at 4℃, washed twice with Phosphate Buffered Saline (DPBS), and treated with 7-AAD (BD Pharmingen, USA) to eliminate dead cells, following the manufacturer’s instructions. The cells were analyzed using an FC500 (Beckman Coulter, USA) or isolated using FACS.
Cells and cryosectioned organoid tissues were fixed with 4% paraformaldehyde and permeabilized with PBS containing 0.5% Triton X-100. After blocking with 5% normal goat serum (Jackson Laboratory, USA) in PBST, the cells were incubated overnight at 4℃ with primary antibodies. The primary antibodies were diluted in PBS with 0.1% normal serum. The cells were then incubated with secondary antibodies at a 1:500 dilution in PBS for 1 hour at room temperature. Finally, the slides were mounted using a mounting medium with DAPI (Vector labs, USA) and imaged using fluorescence microscopy (Olympus Cor-poration, Japan). To eliminate any background fluoresce-nce, negative controls without primary antibodies were included in the experiment. Antibodies used in the research are listed in Table 1.
Table 1 . List of primers and antibodies
qPCR primers | ||
---|---|---|
Gene | Forward | Reverse |
GGGGTTCTATTTGGGAAGGTAT | TGTTGTCAGCTTCCTCCACC | |
CAGAAGGCCTCAGCACCTAC | ATTGGAAGGTTCCCAGTCGG | |
CAGGCCTGCAGCGCCATGAGCAGCCCG | CTGGGGCGGATCCGGGACCTGTCACAC | |
CTTCAAGCACCTGCAGATTC | AGACCTGGATTTCACCGTGT | |
AGGACAAGTACCGCGTGGTCTA | CCTCTGAACGTATGGAGGAGGA | |
GGTTGCACAAAAGTTTATAC | GGCTTGGCGCCCGTGTGCTTCC | |
TCCTGGAATACCCCATACTTAGCA | GCCGCCGCAACTGTTG | |
ACAGCGAAGGGAAATGTAAAAGC | GGGCCCCAGAGACGCTAA | |
TCCTTGGCCGTCTACTGGAA | AGTGGATTAAACGCTAATTCAGTAATAC | |
TGCAAAAAGCGACCTACTACGA | CGTCGGCGCCCAAG | |
AGGTGCAGGCATCCAGGTACT | GGGTTGGCAGCCATGTCTAC | |
TTACCCCTGGATGCAGCGAATG | CCGCGTTAGGTAGCGATTGAAG | |
GTCGCCCACACAGCTCTTCCC | AATAGGAACTCCTTCTCCAGCTC | |
CAGCAAGCACAAAGAGGAGAAGG | AGTTCCAGCGTCTGGTACTTGG | |
TGTGTGAGCGCAGTCTCTACAGA | CGGCCTCAGGTTGGAGAAG | |
AAATGTACTGCCCCAAAGAGCA | ATCCGAGGGATGGGAGACC | |
CCACTGGCTGCTGGACTGTT | TATGACTGGGCCAGGTTCTTTG | |
CTGGGCTACGGCTACCACTTC | GCGATGACTTGAGCGCATT | |
CCACCTTCCCAGCTTGATT | TTAGCCAGCTGGTGGAGACT | |
CCAGTGCCAGCCCAATAGAC | TGGACAATAGCAAAGCGGTTG | |
ATGCTTTCCATCCACTCACC | TTCACTGCTCTCTCCCGTTT | |
TCAGAAGGGTGATGAGTTTGTCC | GGGGCGCTTATGGTCCTTG | |
CGGTTTTGAAGATGAACTCTCAG | GCTCTTCCACCGCCTCTT | |
GCCTGTTCTACTGCAAGTTCCAC | CACAGATGACCACTTTGGTGGC | |
GCCAAGAGAAAGGTTGTGAAGA | GTGTACATGCTGCTCTGGCG | |
GGCCCTGTAATTGGAATGAG | GGCCCTGTAATTGGAATGAG |
Antibodies | ||
---|---|---|
Target | Company | Application |
SOX17 | R&D system, AF1924 | Western blotting, Immunofluorescence |
FOXA2 | Santa Cruz, sc-374376 | Western blotting, Immunofluorescence |
CDX1 | Santa Cruz, sc-398470 | Western blotting, Immunofluorescence |
KLF5 | NOVUS, NBP1-49538 | Western blotting, Immunofluorescence |
SATB2 | Santa Cruz, sc-81376 | Western blotting, Immunofluorescence |
MUC2 | Santa Cruz, sc-515032 | Immunofluorescence |
MUC3 | Santa Cruz, sc-7315 | Western blotting, Immunofluorescence |
MUC4 | Santa Cruz, sc-33654 | Western blotting, Immunofluorescence |
EpCAM | eBioscience, 14-5791-81 | FACS, Immunofluorescence |
CD133 | Santa Cruz, sc-365537 | Immunofluorescence |
Villin | Santa Cruz, sc-58897 | Western blotting, Immunofluorescence |
DEFA5 | NOVUS, NB110-60002 | Western blotting |
CHGA | NOVUS, NBP2-29428 | Western blotting, Immunofluorescence |
LGR5 | Abcam, ab75732 | Western blotting |
TUJ1 | Biolegend, 802001 | Immunofluorescence |
KI-67 | eBioscience, 14-5698-82 | Immunofluorescence |
SOX9 | Cell signaling, 82630 | Immunofluorescence |
Serotonin | Immunostar, 20080 | Immunofluorescence |
P75 NGFR | Santa Cruz, sc-13577 | FACS |
HNK-1 | Sigma Aldrich, C6680 | FACS |
GAPDH | Santa Cruz, sc-47724 | Western blotting |
Substance P | Abcam, ab288318 | ELISA |
CHGA | R&D systems, DY9098-05 | ELISA |
Inhihitors | ||
---|---|---|
Target | Company | Application |
Vapreotide | MCE, HY-P3802 | NK1R antagonist |
Spantide II | MCE, HY-P1722 | NK1R antagonist |
Total RNA was extracted using Trizol (Invitrogen), RNA concentration was measured spectrophotometrically using a Nanodrop (DeNvix Inc., USA). Subsequently, 2 μg of total RNA was reverse transcribed to cDNA using High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher, USA). The quantitative PCR was performed on the StepOne Plus Real-Time PCR system (Applied Biosystems, USA) using AccuPower GreenSrat qPCR PreMix (Bioneer, Korea). Relative mRNA levels were normalized to those of 18S for each gene. The primer sequences are listed in Table 1.
Proteins were separated by SDS-PAGE and transferred onto nitrocellulose (NC) membranes (Bio-Rad, USA) for immunoblotting. Immunoblotting was performed with indicated primary antibodies (Table 1) and relevant secondary antibodies (Thermo Fisher, USA). Immunoblot bands were visualized with chemiluminescence (Pierce, USA) and developed manually using X-ray film (Kodak, USA).
All data were analyzed using GraphPad Prism 9.0 software (GraphPad, USA). The data were presented as mean± standard deviation (SD) of at least three independent biological experiments. Morphological images representative of at least three biologically independent experiments with similar results were captured. The statistical significance was evaluated using paired t-test, unpaired t-tests, one-way ANOVA, or two-way ANOVA as appropriate. A p-value less than 0.05 was considered statistically significant. The bands’ densitometric analysis for immunoblotting was conducted using FIJI software (Image J, USA). FlowJo 10.0 software (Treestar, USA) was utilized to analyze the FACS data. The illustrations were generated using images obtained from biorender.com.
We developed a stepwise protocol for generating colon organoids by modifying previously reported protocols for colonic organoids, which either stimulated BMP signals (14) or did not (15) (Fig. 1A). The differentiation process was characterized by a decrease in the pluripotency markers
After long-term culture, colonic organoids embedded in the ECM matrix exhibited an increase in volume as the ECM matrix was gradually removed (Fig. 2A). At week 6, Mucin proteins (MUC), detectable by MUC2, MUC3, and MUC4 antibodies, accumulated within the organoids (Fig. 2B), indicating the differentiation of epithelial cells, including goblet cells. Flow cytometry analysis of EpCAM-expressing cells revealed that approximately 8% of the cells were epithelial (Fig. 2C). Immunostaining confirmed the formation of an epithelial layer expressing EpCAM, CD133, or Villin on the outer layer of the organoids (Fig. 2D). To identify the various cell types within the epithelial layer, markers representing each cell type were examined. MUC3, MUC4, Villin, defensin alpha 5 (DEFA5), and leucine rich repeat containing G protein-coupled receptor 5 (LGR5) expression were detected (Fig. 2E), indicating the presence of goblet cells, enterocytes, Paneth cells, and colonic stem cells. However, chromogranin A (CHGA) expression, a marker for enteroendocrine cells, was not detected, suggesting that enteroendocrine cells were not present in the epithelial layer of the organoids (Fig. 2E). To assess the functionality of the epithelial cells based on their integrity, we treated the organoids with forskolin and performed a swelling assay based on CF transmembrane conductance regulator (CFTR) activation (20). As a result, we confirmed that the organoids swelled in response to forskolin treatment, indicating the presence of functional epithelial cells (Fig. 2F).
To investigate the reciprocal interaction between immature embryonic colonic tissue and the peripheral nervous system, we co-cultured colon organoids with NCSCs that were differentiated from PHOX2B::eGFP reporter hESCs (18) using a conventional method (21) (Fig. 3A). Within 7 days of co-culture, NCSCs showed morphological characteristics of neuronal differentiation (Fig. 3B), and about 5% of NCSCs expressed eGFP, indicating the expression of PHOX2B (Fig. 3C). FACS sorting was used to isolate NCSCs expressing PHOX2B after co-culture with colon organoids, which showed increased expression of
After co-culturing NCSCs and colon organoids directly for 10 days, differentiated neuronal cells expressing neuron-specific class III beta-tubulin (TUJ1) contained serotonin (Fig. 3J, lower panel), and the epithelial cells of colon organoids labeled with eGFP surrounded by the neuronal cells exhibited typical columnar morphology of colon epithelial cells (Fig. 3J). However, co-culture with NCSCs did not increase the number of epithelial cells expressing EpCAM (Fig. 3K). Instead, the proportion of Ki-67-ex-pressing cells, which are proliferating cells, decreased within the colon organoids (Fig. 3L). When EpCAM-expressing cells were separated from the colon organoids after co-culture with NCSCs and re-plated, epithelial cells expressing EpCAM showed low efficiency for attachment and survival rates while non-epithelial cells that did not express EpCAM exhibited high survival and proliferation rates (Fig. 3M). After 10 days of re-cultivation, most rapidly proliferating cells from EpCAM-expressing cells expressed SOX9, an epithelial stem cell marker in the colon (22) (Fig. 3N).
To investigate the influence of developing neurons on colonic organoids, we examined the time points during co-culture of NCSCs and colonic organoids at which
In this study, we developed a comprehensive protocol for generating colon organoids that closely resemble key features of the developing colon. The protocol involves inducing differentiation of cells towards definitive endoderm, followed by embedding hindgut cells in an artificial extracellular matrix (ECM), and stimulating BMP4 to initiate colonic differentiation. Our hypothesis was that BMP4 plays a crucial role in determining the orientation of cells, particularly the epithelial lining, instead of in overall gut tube formation since it is expressed symmetrically only in the gut tube and is not detectable in the mesentery (25-27). Our findings revealed that adding BMP4 instead of previously used BMP2 (15) during the later stage of the culture period induced the formation of epithelial cells with posterior gut tube specification (19, 28). These organoids exhibited functional epithelial cells such as goblet cells, enterocytes, Paneth cells, and colonic stem cells, as evidenced by the presence of markers such as MUC3, MUC4, Villin, DEFA5, and LGR5 (29, 30). Additionally, the organoids responded to forskolin treatment, indicating the pre-sence of functional epithelial cells (20). Despite these promising results, enteroendocrine cells were not detected in the epithelial layer of the organoids. Thus, further optimization was required to promote their differentiation.
To investigate the interaction between colonic organoids and the peripheral nervous system, we co-cultured colonic organoids with NCSCs. We observed that NCSCs differentiated into enteric NCSCs expressing PHOX2B and neurons expressing TUJ1 (18), while colonic organoids showed abundant mRNA expression for the enterochromaffin cell markers
However, our study has limitations of oversimplifying the complex interaction between developing immature gut and differentiating peripheral neurons. The enteric nervous system in the colon is composed of various types of neurons and enteric glial cells (36), forming complex neural networks in the submucosal and myenteric plexuses (37). To clarify the impact of interactions between immature organoids and developing neurons on the functional maturation of the gut epithelium and the functional specification of neural cells, it is necessary to differentiate the various types of neural cell constituents and conduct further investigations into the precise mechanisms underlying nonsynaptic transmission of substance P.
Despite certain limitations, our research sheds light on the crucial role of immature neurons in the process of development. Our study indicates that even though the colon requires fewer enterochromaffin cells compared to the small intestine, peripheral nerve innervation is essential for the presence of the limited number of enterochro-maffin cells in the colon. Our results also suggest that irregular neural activation or dysfunctional nerve cells that regulate neuropeptides and neurotransmitters such as substance P may lead to abnormal increases in enterochroma-ffin cells in the rectum of irritable bowel syndrome (IBS) patients (38-41). Currently, there is a dearth of research models for neurological disorders like IBS, and our colonic organoids innervated by neurons may prove invaluable for studying relevant mechanisms and developing therapeutic interventions to regulate neuropeptides and neuro-transmitters. Moreover, considering the role of the microbiome in gut health, further studies may explore the interaction between colon organoids and the microbiota in the gut. Understanding the interplay between the microbiota and the nervous system may help unravel the complex mechanisms underlying the development of gastrointestinal disorders and facilitate the development of more effective treatments (42, 43).
Overall, our findings have far-reaching implications for the fields of developmental biology and tissue engineering. The stepwise protocol we used to generate colon organoids can be optimized further to facilitate the differentiation of other cell types in the colonic epithelial cells. Additio-nally, investigating the interaction between colon organoids and the peripheral nervous system can deepen our understanding of the mechanisms that regulate gut development, function, and diseases. Future studies may lead to the development of novel therapeutic interventions for gastrointestinal disorders and enhance our knowledge of the complexities of organ development and function.
This study was supported by the National Research Foundation of Korea (NRF-2022M3A9H1016308, NRF-2022R1F1A1066611, NRF-2023R1A2C2007120), the Ministry of SMEs and startups (S3098634), the Korean Fund for Regenerative Medicine (2021M3E5E5096744), and the KIST Institutional Program (Project No.2Z05790-19-037).
The authors have no conflicting financial interest.
Y.H.C., I.Y.C., and C.E.S.: performing experiments, data analysis, assembly, interpretation, and writing manuscript; C.P., S.K.L., and J.H.K.: performing experiments and data analysis; S.H.S.: performing experiments; S.L. and J.H.P: study design; Y.J.K.: conception, study design, performing experiments, data analysis, assembly, interpretation, and writing a manuscript.
CrossRef (2) |